000			02094 a2200577 4500
005			20250515093915.0
264		0	_c20080122
008			200801s 0 0 eng d
022			_a1744-6872
024	7		_a10.1097/FPC.0b013e3282f1b2be _2doi
040			_aNLM _beng _cNLM
100	1		_aGiusti, Betti
245	0	0	_aCytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10 + 12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients. _h[electronic resource]
260			_bPharmacogenetics and genomics _cDec 2007
300			_a1057-64 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAcute Coronary Syndrome _xblood
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAlleles
650	0	4	_aAryl Hydrocarbon Hydroxylases _xgenetics
650	0	4	_aAspirin _xtherapeutic use
650	0	4	_aClopidogrel
650	0	4	_aCytochrome P-450 CYP2C19
650	0	4	_aCytochrome P-450 CYP3A
650	0	4	_aCytochrome P-450 Enzyme System _xgenetics
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMixed Function Oxygenases _xgenetics
650	0	4	_aPharmacogenetics
650	0	4	_aPlatelet Aggregation _xdrug effects
650	0	4	_aPlatelet Aggregation Inhibitors _xmetabolism
650	0	4	_aPolymorphism, Genetic
650	0	4	_aReceptors, Purinergic P2 _xgenetics
650	0	4	_aReceptors, Purinergic P2Y12
650	0	4	_aTiclopidine _xanalogs & derivatives
700	1		_aGori, Anna Maria
700	1		_aMarcucci, Rossella
700	1		_aSaracini, Claudia
700	1		_aSestini, Ilaria
700	1		_aPaniccia, Rita
700	1		_aValente, Serafina
700	1		_aAntoniucci, Davide
700	1		_aAbbate, Rosanna
700	1		_aGensini, Gian Franco
773	0		_tPharmacogenetics and genomics _gvol. 17 _gno. 12 _gp. 1057-64
856	4	0	_uhttps://doi.org/10.1097/FPC.0b013e3282f1b2be _zAvailable from publisher's website
999			_c17521219 _d17521219